Brief Case Presentation The patient from the previous Pathology Pears post (a 50 year old with history of autoimmune hepatitis status-post liver transplant) presents for…
Brief Case Presentation A 50 year old patient with a history of autoimmune hepatitis status-post liver transplantation approximately four months ago demonstrated the laboratory results…
Check out the first major trial of early LT in patients with AH
A 19-year-old male with past medical history of hypoplastic left heart syndrome s/p Fontan surgery 15 years ago is referred to be seen in hepatology clinic for screening for Fontan associated liver disease (FALD). Which of the following is the best clinical predictor of FALD?
A 45-year-old female underwent colonoscopy for iron deficiency and chronic diarrhea with associated flushing and was found to have an erythematous region in her terminal ileum. Biopsies revealed a neuroendocrine tumor. She undergoes an abdominal MRI showing multiple hepatic lesions and a mass near the terminal ileum. She was referred to oncology and started on octreotide depot injections for symptom control. Liver biopsy confirmed metastatic well-differentiated neuroendocrine tumor with synaptophysin and chromogranin stains positive. An octreotide scan demonstrated multiple avid foci in the liver but no extrahepatic lesions. An echocardiogram showed normal LV and RV function without valvulopathies. She now presents to Hepatology clinic for assessment.
What is the next best step?
Can liver transplantation be an effective therapy for intrahepatic cholangiocarcinoma?
In a very special installment of the Why Series, our adult and pediatric teams join forces to answer the question of how living donor liver transplantation came about in the United States. Read on!
In Episode 4 of “Conversations with an Expert,” Hersh continues to learn about AUD/ALD in an interview with UMich clinical psychologist Dr. Anne Fernandez.
In Episode 3 of the newly-named “Conversations with an Expert,” Hersh chats with Dr. Gerald Scott Winder to learn the psychiatrist’s perspective on alcohol-related liver disease. Enjoy!
In Part 1 of this series, we reviewed what came BEFORE the MELD score—Child-Turcotte-Pugh classification. We additionally discussed the history behind MELD, what is included in its calculation and why, and how it is used in transplant listing. Is everyone excited for Part 2?